Funder
National Natural Science Foundation of China Youth Project
Tianjin Municipal Natural Science Foundation
Tianjin Education Commission Research Project
Medjaden Academy and Research Foundation for Young Scientists
The youth project of Tianjin Health and wellness Commission
Tianjin Science and Technology Planning Project
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference38 articles.
1. Tamura M, Yonezawa T, Liu X, Asada S, Hayashi Y, Fukuyama T, Tanaka Y, Kitamura T, Goyama S (2019) Opposing effects of acute versus chronic inhibition of p53 on decitabine’s efficacy in myeloid neoplasms. Sci Rep 9:8171–8171. https://doi.org/10.1038/s41598-019-44496-6
2. Crochiere ML, Baloglu E, Klebanov B, Donovan S, Del Alamo D, Lee M, Kauffman M, Shacham S, Landesman Y (2016) A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds. Oncotarget 7:1863–1877. https://doi.org/10.18632/oncotarget.6495
3. Fung HY, Chook YM (2014) Atomic basis of CRM1-cargo recognition, release and inhibition. Semin Cancer Biol 27:52–61. https://doi.org/10.1016/j.semcancer.2014.03.002
4. Haase D, Stevenson KE, Neuberg D, Maciejewski JP, Nazha A, Sekeres MA, Ebert BL, Garcia-Manero G, Haferlach C, Haferlach T et al (2019) TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
5. Kitagawa M, Yoshida S, Kuwata T, Tanizawa T, Kamiyama R (1994) p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. Am J Pathol 145:338–344